Investigation of Effectiveness of Telerehabilitation for Zone 2 Flexor Tendon Injuries of the Hand
Launched by ISTANBUL UNIVERSITY · Apr 5, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a home rehabilitation program, called telerehabilitation, for patients with specific hand injuries known as Zone 2 flexor tendon injuries. These injuries can make it difficult for people to use their hands properly, and rehabilitation is crucial for recovery. The trial will involve 42 adults aged 18 to 55 who have had surgery to repair these injuries. Half of the participants will receive in-person therapy at a clinic, while the other half will follow a guided rehabilitation program from home, with regular check-ins by phone and weekly visits to the clinic for monitoring.
To be eligible for the trial, participants must have a specific type of tendon injury and have had surgery within 72 hours of their injury. They should be able to attend sessions regularly and follow the rehabilitation exercises. Throughout the 12-week study, participants will be evaluated on their recovery progress, including how well they can use their hands and any pain they may experience. This trial will help determine if telerehabilitation can be a good alternative to traditional in-person therapy, especially for those who face challenges in accessing clinics.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals with isolated Zone 2 flexor digitorum profundus (FDP) and flexor digitorum superficialis (FDS) injuries,
- • Repair performed within the first 72 hours post-injury,
- • Individuals aged between 18 and 55 years,
- • Patients willing to participate in the study,
- • Ability to attend sessions regularly.
- Exclusion Criteria:
- • Fingers with concomitant fractures, digital nerve injuries, vascular injuries, or significant skin loss accompanying flexor tendon injuries,
- • Bilateral flexor tendon injuries,
- • Patients with replantation or revascularization,
- • Flexor Pollicis Longus tendon injuries of the thumb due to differences in protocols applied and measurement of final outcomes,
- • Patients unable to understand and perform postoperative exercises
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Seda Saka
Study Chair
Halic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported